In BCR::ABL+ chronic myeloid leukemia (CML), SET-mediated PP2A inactivation is essential for the self-renewal of CML leukemic stem cells [27]. Here, PTPA is linked to chronic myelogenous leukemia, BCR-ABL1 positive.